ChemicalBook > Product Catalog >API >Hormones and the Endocrine System >Prostaglandin drugs >(±)-Cloprostenol sodium salt
(±)-Cloprostenol sodium salt
- CAS No.
- 55028-72-3
- Chemical Name:
- (±)-Cloprostenol sodium salt
- Synonyms
- CLOPROSTENOL SODIUM;D-Cloprostenol sodiuM;DL-Cloprostenol sodiuM;16-(3-CHLOROPHENOXY)-9,11,15R-TRIHYDROXY-17,18,19,20-TETRANORPROSTA-5Z,13E-DIEN-1-OIC ACID SODIUM SALT;sodium(Z)-7-((1R,2R,3R,5S)-2-((R,E)-4-(3-chlorophenoxy)-3-hydroxybut-1-en-1-yl)-3,5-dihydroxycyclopentyl)hept-5-enoate;Ciosin;Planate;Estrumat;CLOPROSTENOL NA;15(S)-CLOPROSTENOL
- CBNumber:
- CB7699245
- Molecular Formula:
- C22H30ClNaO6
- Molecular Weight:
- 448.92
- MOL File:
- 55028-72-3.mol
- Modify Date:
- 2023/11/7 16:56:45
| Melting point | 68-70 °C |
|---|---|
| storage temp. | Inert atmosphere,Store in freezer, under -20°C |
| solubility | H2O: >10 mg/mL |
| form | solid |
| color | light brown |
| InChIKey | IFEJLMHZNQJGQU-KXXGZHCCSA-M |
| CAS DataBase Reference | 55028-72-3(CAS DataBase Reference) |
SAFETY
Risk and Safety Statements
| Symbol(GHS) |   GHS07,GHS08 |
|---|---|
| Signal word | Warning |
| Hazard statements | H302-H315-H319-H335-H361 |
| Precautionary statements | P201-P301+P312+P330-P302+P352-P305+P351+P338-P308+P313 |
| Hazard Codes | T |
| Risk Statements | 60-22-36/37/38 |
| Safety Statements | 53-26-36/37/39-45 |
| WGK Germany | 3 |
| HS Code | 2937500000 |
(±)-Cloprostenol sodium salt price More Price(2)
| Manufacturer | Product number | Product description | CAS number | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|---|
| Sigma-Aldrich(India) | C6116 | (+/-)-Cloprostenol sodium salt hydrate ≥98% (HPLC), powder | 55028-72-3 | 1MG | ₹10846.65 | 2022-06-14 | Buy |
| Sigma-Aldrich(India) | C6116 | (+/-)-Cloprostenol sodium salt hydrate ≥98% (HPLC), powder | 55028-72-3 | 5MG | ₹36123.03 | 2022-06-14 | Buy |
(±)-Cloprostenol sodium salt Chemical Properties,Uses,Production
General Description
Cloprostenol sodium (Estrumate)is available as the sodium salt from Bayer AgriculturalDivision or Bayvet Division of Miles Laboratory as an aqueoussolution containing 250 mg/mL.
Biological Activity
Water-soluble prostaglandin F 2 α (PGF 2 α ) analog; acts as a potent FP receptor agonist (EC 50 = 0.84 nM). Potently inhibits differentiation of adipocyte precursor cells. Luteolytic agent in vivo .
Side effects
A low incidence of clostridial and other infections at the injection site has been reported following prostaglandin administration. Treated animals should be closely observed post injection and appropriate antibiotic therapy initiated at the first sign(s) of infection.
Very rarely, anaphylactic reactions have occurred after administration of the product. Overdose: At 50 and 100 times the recommended dose of cloprostenol mild side effects may be detected. These include increased uneasiness, mild transient diarrhea, slight frothing, and milk letdown.
(±)-Cloprostenol sodium salt Preparation Products And Raw materials
Raw materials
Preparation Products
Global( 224)Suppliers
| Supplier | Tel | Country | ProdList | Advantage | Inquiry |
|---|---|---|---|---|---|
| Piramal Pharma Solutions | +919892735994 | Maharashtra, India | 48 | 58 | Inquiry |
| ANVI Pharma | +91-2228995761 +91-2228995761 | Maharashtra, India | 10 | 58 | Inquiry |
| Aspen Biopharma Labs Pvt Ltd | +91-9248058660 +91-9248058662 | Telangana, India | 234 | 58 | Inquiry |
| Apionex Pharma Pvt Ltd | +91-9773830459 +91-9819236256 | Maharashtra, India | 26 | 58 | Inquiry |
| Pharmaffiliates Analytics and Synthetics P. Ltd | +91-172-5066494 | Haryana, India | 6773 | 58 | Inquiry |
| SynZeal Research Pvt Ltd | +1 226-802-2078 | Gujarat, India | 6522 | 58 | Inquiry |
| Omex International | 08048371748Ext 383 | Mumbai, India | 1 | 58 | Inquiry |
| Pharma Affiliates | 172-5066494 | Haryana, India | 6761 | 58 | Inquiry |
| A.J Chemicals | 91-9810153283 | New Delhi, India | 6124 | 58 | Inquiry |
| CLEARSYNTH LABS LTD. | +91-22-45045900 | Hyderabad, India | 6351 | 58 | Inquiry |
| Supplier | Advantage |
|---|---|
| Piramal Pharma Solutions | 58 |
| ANVI Pharma | 58 |
| Aspen Biopharma Labs Pvt Ltd | 58 |
| Apionex Pharma Pvt Ltd | 58 |
| Pharmaffiliates Analytics and Synthetics P. Ltd | 58 |
| SynZeal Research Pvt Ltd | 58 |
| Omex International | 58 |
| Pharma Affiliates | 58 |
| A.J Chemicals | 58 |
| CLEARSYNTH LABS LTD. | 58 |
55028-72-3((±)-Cloprostenol sodium salt)Related Search:
chevron_left
1of4
chevron_right
15-EPI CLOPROSTENOL
15(S)-CLOPROSTENOL
(+)-16-M-CHLOROPHENOXY TETRANOR PROSTAGLANDIN F2ALPHA SODIUM SALT
7-(2-[4-(3-Chlorophenoxy)-3-hydroxy-1-butenyl]-3,5-dihydroxycyclopentyl)-5-heptenoic acid
(5Z)-rel-Cloprostenol SodiuM
(+/-)-16-(3-Chlorophenoxy)-9,11,15R-trihydroxy-17,18,19,20-tetranorprosta-5Z,13E-dien-1-oic acid hydrate sodium salt
(+/-)-Cloprostenol hydrate sodium salt
(5Z)-rel-7-[(1R,2R,3R,5S)-2-[(1E,3R)-4-(3-chlorophenoxy)-3-hydroxy-1-butenyl]-3,5-dihydroxycyclopentyl]-5-heptenoicacidmonosodiumsalt
(+/-)-Cloprostenol sodium salt hydrate,(+/-)-16-(3-Chlorophenoxy)-9,11,15R-trihydroxy-17,18,19,20-tetranorprosta-5Z,13E-dien-1-oic acid sodium salt hydrate
Cloprostenol Sodium (400 mg)
DL-Cloprostenol Sodium Salt
(+/-)-16-(3-Chlorophenoxy)-9,11,15R-trihydroxy-17,18,19,20-tetranorprosta-5Z,13E-dien-1-oic acid sodium salt hydrate
Cloprostenol sodium, >=99%
7-[-2-[4-(3-Chlorophenoxy)-3-hydroxy-1-buten-1-yl]-3,5-dihydroxycyclopentyl]-5-heptenoic acid sodium salt
16-(M-CHLOROPHENOXY)-TETRANOR-PROSTAGLANDIN-F2ALPHA, SODIUM SALT
(+/-)-9ALPHA,11ALPHA,15-TRIHYDROXY-16-(3-CHLOROPHENOXY)-17,18,19,20-TETRANOR-PROSTA-5Z,13E-DIEN-1-OIC ACID, SODIUM SALT
(+/-)-9ALPHA,11ALPHA,15S-TRIHYDROXY-16-(3-CHLOROPHENOXY)-17,18,19,20-TETRANOR-PROSTA-5Z,13E-DIEN-1-OIC ACID
(+)-9ALPHA,11ALPHA,15R-TRIHYDROXY-16-(3-CHLOROPHENOXY)-17,18,19,20-TETRANOR-PROSTA-5Z,13E-DIEN-1-OIC ACID, SODIUM SALT
7-(2-[4-(3-CHLOROPHENOXY)-3-HYDROXY-1-BUTENYL]-3,5-DIHYDROXY-CYCLOPENTYL)-5-HEPTENOIC ACID SODIUM SALT
(5Z)-REL-7-[(1R,2R,3R,5S)-2-[(1E,3R)-4-(3-CHLOROPHENOXY)-3-HYDROXY-1-BUTENYL]-3,5-DIHYDROXYCYCLOPENTYL]-5-HEPTENOIC ACID MONOSODIUM SALT
CLOPROSTENOL NA
(+)-CLOPROSTENOL SODIUM SALT
(+/-)-CLOPROSTENOL SODIUM SALT
CLOPROSTENOL SODIUM SALT
(+)-Cloprostenol Sodium (Subject to Patent Free)
sodium [1alpha(Z),2beta(1E,3R*),3alpha,5alpha]-(±)-7-[2-[4-(3-chlorophenoxy)-3-hydroxybut-1-enyl]-3,5-dihydroxycyclopentyl]hept-5-enoate
(+/-)-CLOPROSTENOL SODIUM SALT HYDRATE
CloprostadilSodium
5-Heptenoic acid, 7-(1R,2R,3R,5S)-2-(1E,3R)-4-(3-chlorophenoxy)-3-hydroxy-1-butenyl-3,5-dihydroxycyclopentyl-, monosodium salt, (5Z)-rel-
Sodium [1alpha(Z),2beta(1E,3R*),3alpha,5alpha]-(+/-)-7-[2-[4-(3-chlorophenoxy)-3-hydroxybut-1-enyl]-3,5-dihydroxycyclopentyl]hept-5-enoate
(5Z)-rel-7-[(1R,2R,3R,5S)-2-[(1E,3S)-4-(3-Chlorophenoxy)-3-hydroxy-1-buten-1-yl]-3,5-dihydroxycyclopentyl]-5-heptenoic Acid Sodium Salt
Ciosin
Estrumat
Planate
sodium(Z)-7-(2-((R,E)-4-(3-chlorophenoxy)-3-hydroxybut-1-en-
Sodium chlorprostaglandin
ICI 80996 sodium salt
(±)-Cloprostenol sodium salt USP/EP/BP
Cloprostenol Sodium (1140666)
16-(3-CHLOROPHENOXY)-9,11,15R-TRIHYDROXY-17,18,19,20-TETRANORPROSTA-5Z,13E-DIEN-1-OIC ACID SODIUM SALT
DL-Cloprostenol sodiuM
D-Cloprostenol sodiuM
CLOPROSTENOL SODIUM
sodium(Z)-7-((1R,2R,3R,5S)-2-((R,E)-4-(3-chlorophenoxy)-3-hydroxybut-1-en-1-yl)-3,5-dihydroxycyclopentyl)hept-5-enoate
(+/-)-Cloprostenol sodium salt hydrate
Sodium (Z)-rel-7-((1R,2R,3R,5S)-2-((R,E)-4-(3-chlorophenoxy)-3-hydroxybut-1-en-1-yl)-3,5-dihydroxycyclopentyl)hept-5-enoate
5-Heptenoic acid, 7-[(1R,2R,3R,5S)-2-[(1E,3R)-4-(3-chlorophenoxy)-3-hydroxy-1-buten-1-yl]-3,5-dihydroxycyclopentyl]-, sodium salt (1:1), (5Z)-rel-
(5Z)-rel-7-[(1R,2R,3R,5S)-2-[(1E,3R)-4-(3-chlorophenoxy)-3-hydroxy-1-buten-1-yl]-3,5-dihydroxycyclopentyl]-5-Heptenoic acid sodium salt (1:1)
Cloprostenol Impurity 5 (DL-Cloprostenol Sodium Salt)
Deferoxamine Impurity 2
55028-72-3
55028-50-8
40665-92-7(62561-03-
C22H28O6ClNa
C22H28ClNaO6
C22H29ClO6
Other APIs
Pharmaceuticals